World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
187
Citations
169037
World Ranking
466
National Ranking
306

Medicine

D-Index
189
Citations
172635
World Ranking
262
National Ranking
175

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

Christopher P. Cannon is affiliated with Brigham and Women's Hospital in the United States and has contributed extensively to the field of medicine, particularly within cardiology and cardiovascular medicine.

Their primary research interests encompass:

  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Venous Thromboembolism Diagnosis and Management
  • Spinal Hematomas and Complications
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Health and Mental Health

Their scholarly work includes publications focused on cardiology and cardiovascular interventions. Frequent publication venues include:

  • Circulation
  • European Heart Journal
  • JACC: Cardiovascular Interventions
  • Journal of the American College of Cardiology
  • UNC Libraries

Notable recent papers by Christopher P. Cannon include:

  • "Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome" (2020) published in Circulation
  • "Ticagrelor-Induced Dyspnea" (2023) published in JACC: Cardiovascular Interventions
  • "TCT CONNECT-58 Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial" (2020) published in Journal of the American College of Cardiology
  • "Acute Clopidogrel Use and Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery" (2021) published in UNC Libraries
  • "ST-Segment Elevation Myocardial Infarction" (2021) published in DeckerMed Transitional Year Weekly Curriculum™

Frequent collaborators contributing to their research efforts include:

  • Shahzad Hassan
  • David Zelle
  • Christian Figueroa
  • Alexander Blood
  • Matthew T. Roe

Best Publications

  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Lars Wallentin;Richard C. Becker;Andrzej Budaj;Christopher P. Cannon

  • Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

    Christopher P. Cannon;Eugene Braunwald;Carolyn H. McCabe;Daniel J. Rader

  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

    Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint

  • Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

    William B. White;Christopher P. Cannon;Simon R. Heller;Steven E. Nissen

  • Predictors of hospital mortality in the global registry of acute coronary events.

    Christopher B. Granger;Robert J. Goldberg;Omar Dabbous;Karen S. Pieper

  • Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibson;Jose L. López-Sendón

  • C-Reactive Protein Levels and Outcomes after Statin Therapy

    Paul M Ridker;Christopher P. Cannon;David Morrow;Nader Rifai

  • TIMI Frame Count A Quantitative Method of Assessing Coronary Artery Flow

    Gibson Cm;Cannon Cp;Daley Wl;Dodge Jt

  • Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

    Christopher P. Cannon;William S. Weintraub;Laura A. Demopoulos;Ralph Vicari

  • Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes

    Elliott M. Antman;Milenko J. Tanasijevic;Bruce Thompson;Mark Schactman

  • The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

    James A. de Lemos;David A. Morrow;Jane H. Bentley;Torbjørn Omland

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis

    David Preiss;Sreenivasa Rao Kondapally Seshasai;Paul Welsh;Sabina A. Murphy

  • Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

    Cannon Cp;Gibson Cm;Lambrew Ct;Shoultz Da

  • Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Jean-François Tanguay

  • Clopidogrel with or without Omeprazole in Coronary Artery Disease

    Deepak L. Bhatt;Deepak L. Bhatt;Byron L. Cryer;Charles F. Contant;Marc Cohen

  • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials

    Colin Baigent;N. Bhala;J. Emberson;A. Merhi

  • Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

    Matthew J. Price;Peter B. Berger;Paul S. Teirstein;Dominick J. Angiolillo

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Deepak L. Bhatt;Michael Szarek;P. Gabriel Steg;Christopher P. Cannon

  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

    Jessica L. Mega;Tabassome Simon;Jean Philippe Collet;Jeffrey L. Anderson

  • Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibsonn;Jose L. Lopez-Sendon

Frequent Co-Authors

Eugene Braunwald
Eugene Braunwald Harvard Medical School
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Sabina A. Murphy
Sabina A. Murphy Brigham and Women's Hospital
David A. Morrow
David A. Morrow Brigham and Women's Hospital
C. Michael Gibson
C. Michael Gibson Beth Israel Deaconess Medical Center
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Carolyn H. McCabe
Carolyn H. McCabe Brigham and Women's Hospital
Robert P. Giugliano
Robert P. Giugliano Brigham and Women's Hospital
Gregg C. Fonarow
Gregg C. Fonarow University of California, Los Angeles
Elliott M. Antman
Elliott M. Antman Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a medical career but unsure about pursuing a traditional MD, there are many related online degree options to consider. For those who want to make an impact in patient care quickly, attending one of the easiest nursing schools to get into can be a practical route, providing faster entry into nursing roles and hands-on healthcare experience.

Other key medical fields include health information and administration. Specializing in medical billing and coding is a great option for those who want to work in healthcare, but not necessarily in a clinical setting. Look for reputable medical billing and coding schools online with financial aid to get started with this fast-growing field.

Some nursing schools make entry even more accessible by not requiring standardized tests. Explore opportunities to start your career at an lpn school without teas test if you want to become an LPN without additional exam requirements.

Lastly, for those looking to enter healthcare management, consider enrolling in a health care administration degree online for flexible and accelerated pathways to leadership roles in hospitals, clinics, and medical offices.

Best Scientists Citing Christopher P. Cannon

Trending Scientists